American Recovery and Reinvestment Act, Section 317 Immunization Funding State Operations Funding and Vaccine
Section 317 Immunization Grantee |
Total |
Alabama |
$2,985,150 |
Alaska |
$539,313 |
Arizona |
$3,741,938 |
Arkansas |
$1,652,144 |
California |
$23,446,251 |
Colorado |
$3,329,406 |
Connecticut |
$2,518,692 |
Delaware |
$664,808 |
District of Columbia |
$346,711 |
Florida |
$10,461,206 |
Georgia |
$6,286,143 |
Hawaii |
$988,990 |
Idaho |
$839,404 |
Illinois 1 |
$8,465,397 |
Indiana |
$4,171,697 |
Iowa |
$2,173,252 |
Kansas |
$2,064,374 |
Kentucky |
$2,686,741 |
Louisiana |
$2,395,546 |
Maine |
$914,194 |
Maryland |
$3,821,205 |
Massachusetts |
$4,266,874 |
Michigan |
$6,612,318 |
Minnesota |
$3,771,258 |
Mississippi |
$1,712,939 |
Missouri |
$3,574,454 |
Montana |
$675,777 |
Nebraska |
$1,314,349 |
Nevada |
$1,821,106 |
New Hampshire |
$1,024,579 |
New Jersey |
$5,936,031 |
New Mexico |
$1,089,701 |
New York 2 |
$12,118,648 |
North Carolina |
$5,153,105 |
North Dakota |
$531,109 |
Ohio |
$7,500,366 |
Oklahoma |
$2,153,981 |
Oregon |
$2,490,016 |
Pennsylvania 3 |
$8,159,088 |
Rhode Island |
$806,923 |
South Carolina |
$2,613,856 |
South Dakota |
$580,657 |
Tennessee |
$3,540,952 |
Texas 4 |
$14,031,941 |
Utah |
$2,231,180 |
Vermont |
$491,557 |
Virginia |
$5,419,971 |
Washington |
$3,925,418 |
West Virginia |
$1,081,814 |
Wisconsin |
$3,905,943 |
Wyoming |
$409,026 |
Total States (and City Grantees) |
$193,437,499 |
Territories |
American Samoa |
$385,000 |
Guam |
$385,000 |
Marshall Islands |
$215,000 |
Federated States of Micronesia |
$385,000 |
Nothern Marianas |
$337,000 |
Palau |
$180,000 |
Puerto Rico |
$2,295,501 |
Virgin Islands |
$380,000 |
Total Territories |
$4,562,501 |
Total States/Cities/Territories 5 |
$198,000,000 |
Undistributed Additional State Vaccine Purchase 6 |
$50,000,000 |
Evaluation |
$500,000 |
CDC scientific and technical support |
$1,500,000 |
Total
7
|
$250,000,000 |
1 Illinois includes operating funding and vaccine going to Chicago grantee ($1,523,637).
2 New York includes operating funding and vaccine going to New York City grantee ($4,572,412).
3 Pennsylvania includes operating funding and vaccine going to Philadelphia grantee ($966,663).
4 Texas includes operating funding and vaccine going to Houston ($441,625) and San Antonio ($947,590) grantees.
5 Grantee totals do not include funding for which grantees will have the opportunity to compete at a later date. Totals include operations funding and CDC-purchased vaccine that will be made available to the States.
6 A portion of these funds may be used to support innovative initiatives for vaccine purchase in schools and the community.
7 An additional $18 million in operations funding will be made available to Section 317 grantees competitively to support the innovative projects , including the vaccination projects in schools and other community settings. |